Stockreport

GH Research Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]

GH Research PLC - Ordinary Shares  (GHRS) 
PDF GH Research PLC Completed Phase 2b trial of GH001 in TRD and presented the full dataset at the 2025 ASCP and ECNP congresses GH001 cleared by FDA for U.S. clinical [Read more]